Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02119676
Title Study of Ruxolitinib in Colorectal Cancer Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Age Groups: adult
Covered Countries USA | GBR | FRA | ESP | DEU | AUS

No variant requirements are available.